Correction to “Neuroprotective Effect of Ceftriaxone on MPTP‐Induced Parkinson’s Disease Mouse Model by Regulating Inflammation and Intestinal Microbiota”
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsParkinson's Disease Mechanisms and Treatments · Gut microbiota and health · Pharmacological Receptor Mechanisms and Effects
X. Zhou, J. Lu, K. Wei, J. Wei, P. Tian, M. Yue, Y. Wang, D. Hong, F. Li, B. Wang, T. Chen, and X. Wang, “Neuroprotective Effect of Ceftriaxone on MPTP‐Induced Parkinson’s Disease Mouse Model by Regulating Inflammation and Intestinal Microbiota” Oxidative Medicine and Cellular Longevity, vol. 2021 (2021). https://doi.org/10.1155/2021/9424582.
In the article titled “Neuroprotective Effect of Ceftriaxone on MPTP‐Induced Parkinson’s Disease Mouse Model by Regulating Inflammation and Intestinal Microbiota,” there was an error in Figure 2a. More specifically, the panels depicting the immunofluorescence staining of the FMT group share overlapping features with the panels representing the M group. These errors were introduced by the authors during figure assembly and should be corrected as follows:
We apologize for these errors.